journal
MENU ▼
Read by QxMD icon Read
search

Drug and Therapeutics Bulletin

journal
https://www.readbyqxmd.com/read/30361209/conditional-approval-who-knows
#1
EDITORIAL
Henry Fok, Khong Teck, David Phizackerley
No abstract text is available yet for this article.
October 25, 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/30297452/does-melatonin-improve-sleep-in-children-with-neurodevelopmental-disorders
#2
(no author information available yet)
Review of : Abdelgadir IS et al Melatonin for the management of sleep problems in children with neurodevelopmental disorders: a systematic review and meta-analysis. Archives Dis Child 2018. doi: 10.1136/archdischild-2017-314181. [Epub ahead of print 2 May 2018].
October 8, 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/30297446/mhra-drug-safety-update-denosumab-xgeva-and-rebound-hypercalcaemia
#3
(no author information available yet)
Review of : Medical and Healthcare products Regulatory Agency. Denosumab for giant cell tumor of bone: risk of clinically significant hypercalcaemia following discontinuation. Drug Safety Update 2018;11(11);2.
October 8, 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/30470710/case-of-drug-induced-interstitial-lung-disease-secondary-to-adalimumab
#4
Seema Alaee, Quentin Jones
In conjunction with BMJ Case Reports, DTB will feature occasional drug-related cases that are likely to be of interest to readers. These will include cases that involve recently marketed drugs for which there is limited knowledge of adverse effects and cases that highlight unusual reactions to drugs that have been marketed for several years.
December 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/30470709/written-information-on-medicines-for-patients-learning-from-the-pil
#5
REVIEW
D K Theo Raynor
No abstract text is available yet for this article.
December 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/30470708/omega-3-fatty-acid-supplements-do-not-improve-symptoms-of-dry-eye-disease
#6
(no author information available yet)
Review of : The Dry Eye Assessment and Management Study Research Group. N-3 fatty acid supplementation for the treatment of dry eye disease. NEJM 2018;378:1681-90.
December 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/30470707/intensive-antihypertensive-treatment-and-serious-adverse-events-in-older-people
#7
(no author information available yet)
Review of : Sink KM, et al Syncope, hypotension and falls in the treatment of hypertension: results from the randomized clinical systolic blood pressure intervention trial. J Am Ger Soc 2018;66:679-86.
December 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/30355723/spontaneous-splenic-rupture-due-to-rivaroxaban
#8
Vinayak Nagaraja, Greg Cranney, Virag Kushwaha
In conjunction with BMJ Case Reports , DTB will feature occasional drug-related cases that are likely to be of interest to readers. These will include cases that involve recently marketed drugs for which there is limited knowledge of adverse effects and cases that highlight unusual reactions to drugs that have been marketed for several years.
November 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/30355722/restrictions-on-travelling-with-medicines
#9
REVIEW
James Cave
No abstract text is available yet for this article.
November 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/30297451/exercise-is-an-important-intervention-for-treating-intermittent-claudication
#10
(no author information available yet)
Review of : Lane R et al Exercise for intermittent claudication. Cochrane Database of Syst Revs 2017;12:10.1002/14651858.CD000990.pub4.
November 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/30297450/ideal-model-of-care-for-multimorbidity-the-search-continues
#11
EDITORIAL
J Treadwell
No abstract text is available yet for this article.
November 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/30297449/ulipristal-acetate-esmya-restrictions-on-use
#12
(no author information available yet)
Safety alert : Esmya (ulipristal acetate) for symptoms of uterine fibroids: restrictions to use and requirement to check liver function before, during and after treatment.1,2.
November 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/30297448/five-day-nitrofurantoin-is-better-than-single-dose-fosfomycin-at-resolving-uti-symptoms
#13
(no author information available yet)
Review of : Huttner A et al Effect of 5-day nitrofurantoin vs single dose fosfomycin on clinical resolution of uncomplicated lower urinary tract infection in women. JAMA 2018;319(17):1781-9.
November 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/30297447/audit-of-copd-exacerbations-in-secondary-care
#14
(no author information available yet)
Review of : Review of: Stone RA et al COPD: working together. National Chronic Obstructive Pulmonary Disease (COPD) Audit Programme: clinical audit of COPD exacerbations admitted to acute hospitals in England and Wales. 2017 National Clinical Audit Report. London. RCP, April 2018.
November 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/30297445/non-adherence-to-prescribing-guidelines-for-reduced-kidney-function-puts-older-people-at-risk
#15
(no author information available yet)
Review of : Wood S et al Application of prescribing recommendations in older people with reduced kidney function: a cross-sectional study in general practice. Br J Gen Practice 2018; 68: e378-87.
November 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/29980592/correction-an-update-on-the-management-of-gout
#16
(no author information available yet)
No abstract text is available yet for this article.
November 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/30254064/sildenafil-from-pom-to-p
#17
(no author information available yet)
No abstract text is available yet for this article.
October 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/30254063/where-now-for-opioids-in-chronic-pain
#18
Cathy Stannard
No abstract text is available yet for this article.
October 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/30254062/diclofenac-inferior-to-norfloxacin-for-symptom-relief-of-lower-utis
#19
(no author information available yet)
Review of : Kronenberg A et al. Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial. BMJ 2017; 359: j4784.
October 2018: Drug and Therapeutics Bulletin
https://www.readbyqxmd.com/read/30254061/ambulatory-versus-clinic-blood-pressure-measurement-more-evidence
#20
(no author information available yet)
Review of : Banegas J et al. Relationship between clinic and ambulatory blood pressure measurements and mortality. New Engl J Med 2018; 378: 1509-20.
October 2018: Drug and Therapeutics Bulletin
journal
journal
21685
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"